亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Duration of bisphosphonate treatment: results of a non-randomised study in patients previously treated with local irradiation for bone metastases from breast cancer

医学 乳腺癌 双膦酸盐 外科 放射治疗 临床终点 骨痛 性能状态 并发症 随机对照试验 转移性乳腺癌 癌症 内科学 骨质疏松症 化疗
作者
Vassilis Kouloulias,John Kouvaris,Kyriaki Mystakidou,Maria N. Varela,John D. Kokakis,Kyriaki Pistevou-Gombaki,M. Balafouta,C. Gennatas,Lambros J. Vlahos
出处
期刊:Current Medical Research and Opinion [Taylor & Francis]
卷期号:20 (6): 819-826 被引量:4
标识
DOI:10.1185/030079904125003331
摘要

PURPOSE: To assess whether disodium pamidronate (DP) once started should be given life-long in women with lytic bone metastases. PATIENTS AND METHODS: One hundred and three women with breast cancer who had at least one osteolytic lesion received 180 mg of DP as a 2-h intravenous infusion given every 4 weeks for a life-time, following local radiotherapy. After six cycles, 26 out of 103 patients (25%) refused to continue their bisphosphonate-treatment. Thus two groups were constituted: non-stop (group A) and premature discontinued (group B). The new skeletal complication free survival (NSCFS) was the primary endpoint verified during extramural review. Performance status, pain-score and biochemical markers were secondary endpoints. RESULTS: Generally DP was well tolerated. At 36 months, the proportion of patients having had any skeletal complication was 54.5 and 84.6% in group A and B, respectively. The median time of NSCFS was apparently longer for group A. In group A, the pain score and the ECOG status were significantly lower, while the overall survival appeared to be longer. Multivariate analysis revealed age, nodal status and interruption of treatment as prognostic factors to NSCFS, with relative risk 1.05, 2.3 and 1.5 respectively. CONCLUSION: Data concerning the suspension of new skeletal complications, as well as the apparent improvement of overall survival, pain score and ECOG status, suggest that the pamidronate-treatment should not be stopped once started. These results should be confirmed in a randomised trial.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
yinh完成签到 ,获得积分10
3秒前
乐观小蕊完成签到 ,获得积分10
3秒前
369ninja发布了新的文献求助10
3秒前
Cupid完成签到,获得积分10
9秒前
洪亮发布了新的文献求助30
9秒前
10秒前
13秒前
159357发布了新的文献求助30
14秒前
可爱馒头完成签到,获得积分10
14秒前
14秒前
16秒前
传奇3的应助被Flynn采纳,获得10
17秒前
yangzai完成签到 ,获得积分0
18秒前
19秒前
李华完成签到,获得积分10
20秒前
20秒前
欣喜的若山完成签到 ,获得积分10
20秒前
黄天完成签到 ,获得积分10
21秒前
小叶子完成签到 ,获得积分10
22秒前
llqq完成签到,获得积分10
22秒前
洪亮完成签到,获得积分10
23秒前
李华发布了新的文献求助10
24秒前
25秒前
25秒前
25秒前
林诗萍完成签到 ,获得积分10
26秒前
Flynn发布了新的文献求助10
30秒前
清汐完成签到 ,获得积分10
30秒前
阿腾发布了新的文献求助10
31秒前
35秒前
loii的应助被务实的小凡采纳,获得50
35秒前
小马甲的应助被阿腾采纳,获得10
36秒前
38秒前
38秒前
Flynn完成签到,获得积分10
39秒前
陈鑫龙完成签到 ,获得积分10
39秒前
40秒前
liugaoleng完成签到 ,获得积分10
42秒前
42秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179656
求助须知:如何正确求助?哪些是违规求助? 9569921
关于积分的说明 21807706
捐赠科研通 7775141
什么是DOI,文献DOI怎么找? 3433072
关于科研通互助平台的介绍 2557032
邀请新用户注册赠送积分活动 2478778